https://www.cruxal.in/news/symbiotec-pharmalab-q1-fy27-consol-revenue-rs-218-20-cr-pat-c9ae406f 2026-09-21T16:13:21.173758Z Cruxal en 2026-09-21T16:13:21.173758Z Symbiotec Pharmalab Q1 FY27: Consol revenue Rs 218.20 cr, PAT Rs 14.10 cr https://www.cruxal.in/api/og?name=Symbiotec+Pharmalab+Ltd&ticker=SYMBIOTEC&headline=Symbiotec+Pharmalab+Q1+FY27%3A+Consol+revenue+Rs+218.20+cr%2C+PAT+Rs+14.10+cr&logo=&tpl=results&period=Q1+FY27&kpi=Revenue~Rs+218.20+cr~%2B7.4%25%7CPAT~Rs+14.10+cr~-52.8%25&bg=default%2F06&v=4 Symbiotec Pharmalab Q1 FY27: Consol revenue Rs 218.20 cr, PAT Rs 14.10 cr